Cardiac Sarcoidosis Randomized Trial — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(30 sites)
United States
Yale-New Haven Hospital, New Haven, Connecticut Tufts Medical Center, Boston, Massachusetts University of Michigan-Michigan Medicine Cardiovascular Center, Ann Arbor, Michigan University of Minnesota, Minneota, Minnesota Montefiore Medical Center, New York, New York The Ohio State University Wexner Medical Center, Columbus, Ohio Allegheny General Hospital, Pittsburgh, Pennsylvania University of Utah, Salt Lake City, Utah Virginia Commonwealth University, Richmond, Virginia Canada
Libin Cardiovascular Institute of Alberta, Calgary, Alberta St. Paul's Hospital, Vancouver, British Columbia Eastern Health Health Sciences Centre, St. John's, Newfoundland and Labrador QE II Health Sciences Centre, Halifax, Nova Scotia St. Joseph's Healthcare Centre, Hamilton, Ontario London Health Sciences Centre, London, Ontario University of Ottawa Heart Institute, Ottawa, Ontario Montreal Heart Institute, Montreal, Quebec CIUSSS-Hopital du Sacre-Coeur de Montreal, Montreal, Quebec Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Québec, Quebec CIUSSS de l'Estrie - CHUS - Hôpital Fleurimont, Sherbrooke, Quebec Japan
Hokkaido University, Sapporo, Kita 8, Nishi 5, Kita-Ku University of Fukui, Fukui St. Marrianna University, Kawasaki Nagoya City University, Nagoya National Cerebral and Cardiovascular Center (NCVC), Osaka Sapporo Medical University, Sapporo Nippon Medical School, Tokyo United Kingdom
King's College Hospital NHS Foundation Trust, London Imperial College Healthcare Trust-NHS-Hammersmith Hospital, London Age range
18 Years and older
Last updated December 2024